Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
WALTHAM, Mass., Jan. 29 -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that it will present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference being held at the Grand Hyatt Hotel in New York City. The company will present on Thursday, February 7, 2008, at 9:20 am (EST).
Marijn E. Dekkers, president and chief executive officer of Thermo Fisher Scientific, will provide an overview of the company and discuss its expectations for future financial performance.
You may listen to the presentation live on our Website, www.thermofisher.com/, by clicking on "Investors." An audio archive of the Webcast will be available in that section of our Website under "Webcasts and Presentations" through Friday, March 7, 2008.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE:TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com/.
FCMN Contact: investorrelations@thermo.com
Source: Thermo Fisher Scientific Inc.
CONTACT: Media, Karen Kirkwood, +1-781-622-1306, Karen.Kirkwood@thermofisher.com,
or Investors, Ken Apicerno, +1-781-622-1111, ken.apicerno@thermofisher.com, both of Thermo Fisher Scientific Inc.
Web site: http://www.thermofisher.com/
